Neutralizing capacity of antisera raised in horses and rabbits against Crotalus durissus terrificus (South American rattlesnake) venom and its main toxin, crotoxin

Toxicon

Volumn 37, Issue 10, 1999, Pages 1341-1357

  Oshima Franco, Y ^a   Hyslop, S ^a   Prado Franceschi, J ^a   Cruz Hofling M A ^a   Rodrigues Simioni, L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CROTOXIN; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DIAPHRAGM; DRUG MANUFACTURE; ENVENOMATION; HORSE; IN VITRO STUDY; MOUSE; NEUROMUSCULAR BLOCKING; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RABBIT; SKELETAL MUSCLE;

ANIMALS; ANTIVENINS; CROTALID VENOMS; CROTOXIN; HORSES; IMMUNE SERA; MALE; MICE; MUSCLES; NEUROMUSCULAR BLOCKADE; NEUTRALIZATION TESTS; PHRENIC NERVE; RABBITS;

CROTALUS; CROTALUS DURISSUS TERRIFICUS; EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 0033028306     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00246-3     Document Type: Article

References (51)

1. Alexander G., Grothusen J., Zepede H., Schwartzman R.J. Gyroxin, a toxin from the venom of Crotalus durissus terrificus, is a thrombin-like enzyme. Toxicon. 26:1988;953-960.
2. Amaral C.F.S., Rezende N.A., Campolina D., Dias M.B., Chávez-Olórtegui C., Penaforte C.L., Diniz C.R. Time factor in the detection of circulating whole venom and crotoxin and efficacy of antivenom therapy in patients envenomed by Crotalus durissus. Toxicon. 35:1997;699-704.
3. Azevedo-Marques M.M., Cupo P., Coimbra T.M., Hering S.E., Rossi M.A., Laure C.J. Myonecrosis, myoglobinuria and acute renal failure induced by South American rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon. 23:1982;631-636.
4. Barbosa C.F., Rodrigues R.J., Cháves-Olórtegui C., Sanchez E.F., Heneine L.G.D. Determination of the neutralizing potency of horse antivenom against bothropic and crotalic venoms by indirect enzyme immunoassay. Braz. J. Med. Biol. Res. 28:1995;1077-1080.
5. Barral-Netto M., von Sohsten R.L. Serum kinetics of crotoxin from Crotalus durissus terrificus venom in mice: evidence for a rapid clearance. Toxicon. 29:1991;527-531.
6. Barrio A. Estudo electroforético del veneno de serpiente de cascabel. Cien. Invest. 10:1954;368-370.
7. Barrio A. Gyroxin, a new neurotoxin of Crotalus durissus terrificus venom. Acta Physiol. Latinoamer. 11:1961;224.
8. 2 neurotoxin. Acta Physiol. Pharmacol. Latinoamer. 39:1989;439-448.
9. Bon C., Changeaux J.-P., Jeng T.-W., Fraenkel Conrat H. Postsynaptic effects of crotoxin and of its isolated subunits. Eur. J. Biochem. 99:1979;471-481.
10. Brazil V. Contribuição ao estudo do veneno ophidico, III. Tratamento das mordeduras de cobras. Rev. Med. São Paulo. 6:1903;265-278.
11. Breithaupt H. Neurotoxic and myotoxic effects of Crotalus phospholipase A and its complex with crotapotin. Naunyn-Schmiedebergs Arch. Pharmacol. 292:1976;271-278.
12. Breithaupt H., Rübsamen K., Habermann E. Biochemistry and pharmacology of the crotoxin complex. Biochemical analysis of crotapotin and basic Crotalus phospholipase A. Eur. J. Biochem. 60:1974;333-345.
13. Bülbring E. Observation on the isolated phrenic nerve-diaphragm preparation of the rat. Br. J. Pharmacol. 1:1946;38-61.
14. Carafoli E. Mitochondrial uptake of calcium ions and the regulation of cell function. Biochem. Soc. Symp. 39:1974;89.
15. Chang C.C., Lee C.Y. Crotoxin, the neurotoxin of South American rattlesnake venom, is a presynaptic toxin like β-bungarotoxin. Naunyn-Shmiedebergs Arch. Pharmacol. 296:1977;159-168.
16. Chávez-Olórtegui C., Penaforte C.L., Silva R.R., Ferreira A.P., Rezende N.A., Amaral C.F., Diniz C.R. An enzyme-linked immunosorbent assay (ELISA) that discriminates between the venoms of Brazilian Bothrops species and Crotalus durissus. Toxicon. 35:1997;253-260.
17. Cruz-Höfling M.A., Silva-Carvalho I., Leite G.B., Corrado A.P., Rodrigues-Simioni L. Myonecrosis induced by guanidine in the mouse isolated phrenic nerve diaphragm preparation. Gen. Pharmacol. 28:1997;593-597.
18. Cupo P., Azevedo-Marques M.M., Hering S.E. Clinical and laboratory features of South American rattlesnake (Crotalus durissus terrificus) envenomation in children. Trans. R. Soc. Trop. Med. Hyg. 82:1988;924-929.
19. Dixon R.W., Harris J.B. Myotoxic activity of the toxic phospholipase, notexin, from the venom of the Australian tiger snake. J. Neuropathol. Exp. Neurol. 55:1996;1230-1237.
20. Faure G., Bon C. Several isoforms of crotoxin are present in individual venoms from the South American rattlesnake Crotalus durissus terrificus. Toxicon. 25:1987;229-234.
21. 2 neurotoxin from the South American rattlesnake Crotalus durissus terrificus: purification of several isoforms and comparison of their molecular structure and of their biological activities. Biochemistry. 27:1988;730-738.
22. Freitas T.V., Fortes-Dias C.L., Diniz C.R. Protection against the lethal effects of Crotalus durissus terrificus (South American rattlesnake) venom in animals immunized with crotoxin. Toxicon. 28:1990;1491-1496.
23. Gonçalves J.M., Vieira L.G. Estudos sobre venenos de serpentes brasileiras, I. Análise eletroforética. Ann. Acad. Bras. Ciên. 22:1950;141-150.
24. 2 complex. Toxicon. 22:1984;85-98.
25. Gutiérrez, J.M., Rojas, G., Lomonte, B., Gené, J.A. and Chaves, F., 1990. La evaluacíon de la capacidad neutralizante de los antivenenos en America. Publicacíon del Instituto Clodomiro Picado, Universidad de Costa Rica, 20p.
26. 2 crotapotin complex isolated from venom of the South American rattlesnake. Br. J. Pharmacol. 61:1977;597-606.
27. Hendon R.A., Fraenkel-Conrat H. Biological role of the two components of crotoxin. Proc. Natl. Acad. Sci. USA. 68:1971;1560-1563.
28. Herbert W.J. Mineral oil adjuvants and the immunization of laboratory animals. Weir D.M. Handbook of Experimental Immunology. Vol. 3:1978;Oxford, Blackwell Scientific.
29. Horst J., Hendon R., Fraenkel-Conrat H. The active components of crotoxin. Biochem. Biophys. Res. Commun. 46:1972;1042-1047.
30. Hurn B.A.L., Chantler S.M. Production of reagent antibodies. Meth. Enzymol. 70:1980;104-143.
31. Jorge M.T., Cardoso J.L., Castro S.C.B.A., Ribeiro L.A., Franca F.O.S., de Almeida M.E., Kamiguti A.S., Santo-Martins I.S., Santoro M.L., Mancau J.E.C., Sbrogio M.L., Theakston R.D.G., Warrell D.A. A randomised blinded comparison of two doses of antivenom in the treatment of Bothrops envenoming in São Paulo. Bras. Trans. R. Soc. Trop. Med. Hyg. 89:1995;111-114.
32. Landucci E.C.T., Condino-Neto A., Perez A.C., Hyslop S., Corrado A.P., Novello J.C., Marangoni S., Oliveira B., Antunes E., Nucci G. Crotoxin induces aggregation of human washed platelets. Toxicon. 32:1994;217-226.
33. Manual de Vigilância Epidemiológica, 1993. Acidentes por animais peçonhentos, Identificação, diagnóstico e tratamento. Secretaria de Estado da Saúde de São Paulo, SP, 61 p.
34. Melo P.A., Ownby C.L. Different sensitivity of fast- and slow-twitch muscles to some snake venoms and myotoxins. Toxicon. 34:1996;653-669.
35. Ministério da Saúde, 1991. Cartilha de Ofidismo (Cobral). Programa Nacional de Ofidismo, Brasília, DF, 32p.
36. Nahas L., Denson K.W.E., MacFarlane R.G. A study of the coagulant action of eight snake venoms. Thromb. Diathes. Haemorrh. 12:1964;355-367.
37. Ouchterlony O. Antigen-antibody reactions in gels. Acta Pathol. Microbiol. Scand. 26:1949;507-515.
38. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;357-363.
39. Prado-Franceschi J., Vital Brazil O. Convulxin, a new toxin from the venom of the South American rattlesnake Crotalus durissus terrificus. Toxicon. 19:1981;875-887.
40. Preston S., Davis C.E., Harris J.B. The assessment of muscle fibre loss after the injection of the venom of Notechis scutatus (Australian tiger snake). Toxicon. 28:1990;201-214.
41. Raw I., Rocha M.C., Esteves M.I., Kamiguti A.S. Isolation and characterization of a thrombin-like enzyme from the venom of Crotalus durissus terrificus. Braz. J. Med. Biol. Res. 19:1986;333-338.
42. Rosenfeld G. Symptomatology, pathology and treatment of snakebites in South America. Bücherl W., Bucley E.E., Deulofeu V. Venomous Animals and their Venoms. Vol. II:1971;345-384 Academic Press, New York.
43. Rübsamen K., Breithaupt H., Habermann E. Biochemistry and pharmacology of the crotoxin complex, I. Subfractionation and recombination of the crotoxin complex. Naunyn-Schmiedebergs Arch. Pharmacol. 270:1971;274-288.
44. Slotta K.H., Fraenkel-Conrat H. Schlangengifte, III. Mitteilung Reiningung und Krystallization des Klapperschlangengiftes. Ber. Dtch. Chem. Ges. 71:1938;1076-1081.
45. Storella R.J. Jr., Baker T. Activity-dependent differences between fast and slow neuromuscular systems. Eur. J. Pharmacol. 145:1988;299-304.
46. Suarez-Kurtz G. Release of creatine kinase from frog muscle by osmotic changes. Am. J. Physiol. 242:1982;398-403.
47. Theakston R.D.G., Fan H.W., Warrell D.A., da Silva W.D., Ward S.A., Higashi H.D. Use of enzyme immunoassay to compare the effect and assess the dosage regimens of three Brazilian Bothrops antivenoms. Am. J. Trop. Med. Hyg. 47:1992;593-604.
48. Vital Brazil O. Pharmacology of crystalline crotoxin, II. Neuromuscular blocking action. Mem. Inst. Butantan. 33:1966;981-992.
49. Vital Brazil O. Neurotoxins from the South American rattlesnake venom. J. Formosan Med. Assoc. 71:1972;394-400.
50. Vital Brazil O. Peçonhas. Corbett C.E. Farmacodinâmica. 6th Edition :1982;1044-1074 Guanabara Koogan, Rio de Janeiro.
51. Vital Brazil O., Excell B.J. Action of crotoxin and crotactin from the venom of Crotalus durissus terrificus (South American rattlesnake) on the frog neuromuscular junction. J. Physiol. 212:1971;34-35.